Integral Derivatives’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ICPT
CG
O
Integral Derivatives's ICPT Position: Q2 2015 in Review
Integral Derivatives sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2015, closing a stake of 758 shares — an estimated $202K sold.
Integral Derivatives first reported a position in ICPT in Q1 2014 and held it in 3 quarters. The position peaked at $2.28M in Q2 2014. 191 funds tracked by Wall St. Rank hold ICPT as of Q2 2015.
- Integral Derivatives reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
- Integral Derivatives sold 758 Intercept Pharmaceuticals, Inc. shares in Q2 2015, an estimated $202K.
- Integral Derivatives first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
- Integral Derivatives's Intercept Pharmaceuticals, Inc. position peaked at $2.28M in Q2 2014.
- 191 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2015.
Based on Integral Derivatives's 13F filing for Q2 2015, filed 15 Jul 2015.